Russian Biotech Firm Aims for First Human-Compatible Pig Organ by 2027

NOVOSIBIRSK, March 11 – A Russian biotechnology company has announced an ambitious timeline to grow the country's first genetically modified mini-pig designed as a potential organ donor for humans. According to Eduard Chuyko, head of the M-Genomics firm based in the Novosibirsk Academpark, the initial animal could be ready by early 2027.

Chuyko told RIA Novosti that with the necessary infrastructure and funding, the first pig could be produced in under a year, though a more realistic target is the first half of 2027. The project's ultimate goal is to establish a viable pipeline for xenotransplantation—the transplant of animal organs into humans—by 2030. The kidney is the primary organ being developed.

Scientists acknowledge the early stages will be limited. The first modified organs would not last for months or years, but could potentially sustain a patient for days without rejection. This 'bridge' organ could save lives by supporting patients awaiting a human donor transplant.

The research team, which includes specialists from the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences and the Meshalkin National Medical Research Center, reports no current scientific roadblocks. The primary challenges are financial and logistical. "The project is expensive and long-term," Chuyko said, inviting interested partners to collaborate. If successful, the work could offer a new solution to the global shortage of transplantable organs.